Neosoma, Inc.

Neosoma, Inc. has 2 AI-enabled medical devices on the FDA list. The first decision was on September 27, 2022 and the most recent on December 17, 2025 (Neosoma Brain Mets). Its most common review panel is Radiology (2 devices).